TABLE 1.
Clinicopathological characteristics | Number of SC/ASC (%) | Number of AC (%) | P |
Gender | |||
Male | 25 (36.2) | 61 (41.8) | 0.438 |
Female | 44 (63.8) | 85 (58.2) | |
Age | |||
≤45 years | 3 (4.3) | 20 (13.7) | 0.038 |
>45 years | 66 (95.7) | 126 (86.3) | |
Differentiation | |||
Well | 19 (27.5) | 51 (34.9) | 0.308 |
Moderate | 33 (47.8) | 54 (37.0) | |
Poor | 17 (24.6) | 41 (28.1) | |
Maximum tumor diameter | |||
≤3 cm | 39 (56.5) | 90 (61.6) | 0.474 |
>3 cm | 30 (43.5) | 56 (38.4) | |
Cholecystolithiasis | |||
No | 31 (44.9) | 78 (53.4) | 0.245 |
Yes | 38 (55.1) | 68 (46.6) | |
TNM stages | |||
I + II | 29 (42.0) | 77 (52.7) | 0.143 |
III + IV | 40 (58.0) | 69 (47.3) | |
Lymph node metastasis | |||
No | 27 (39.1) | 80 (54.8) | 0.032 |
Yes | 42 (60.9) | 66 (45.2) | |
Locoregional invasion | |||
No | 24 (34.8) | 72 (49.3) | 0.045 |
Yes | 45 (65.2) | 74 (50.7) | |
Surgical methods | |||
Radical | 27(39.1) | 75 (51.4) | 0.223 |
Palliative | 28 (40.6) | 50 (34.2) | |
Without resection | 14 (20.3) | 21 (14.4) | |
XRCC1 | |||
− | 28 (40.6) | 58 (39.7) | 0.905 |
+ | 41 (59.4) | 88 (60.3) |
−, negative expression; +, positive expression.